Dr. Lal PathLabs Limited (IN:LALPATHLAB)
:LALPATHLAB
Total Valuation
Dr. Lal PathLabs Limited has a market cap or net worth of ₹228.85B. The enterprise value is ₹224.58B.
Market Cap₹228.85B
Enterprise Value₹224.58B
Share Statistics
Dr. Lal PathLabs Limited has 167,555,020 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding167,555,020
Owned by Insiders―
Owned by Institutions0.04%
Financial Efficiency
Dr. Lal PathLabs Limited’s return on equity (ROE) is 0.22 and return on invested capital (ROIC) is 18.22%.
Return on Equity (ROE)0.22
Return on Assets (ROA)0.18
Return on Invested Capital (ROIC)18.22%
Return on Capital Employed (ROCE)0.24
Revenue Per Employee6.00M
Profits Per Employee1.19M
Employee Count4,099
Asset Turnover0.91
Inventory Turnover22.80
Valuation Ratios
The current PE Ratio of Dr. Lal PathLabs Limited is 68.4. Dr. Lal PathLabs Limited’s PEG ratio is 1.15.
PE Ratio68.4
PS Ratio8.13
PB Ratio9.21
Price to Fair Value9.21
Price to FCF38.16
Price to Operating Cash Flow70.31
PEG Ratio1.15
Income Statement
In the last 12 months, Dr. Lal PathLabs Limited had revenue of 24.61B and earned 4.87B in profits. Earnings per share was 29.24.
Revenue24.61B
Gross Profit16.38B
Operating Income5.60B
Pretax Income6.25B
Net Income4.87B
EBITDA7.89B
Earnings Per Share (EPS)29.24
Cash Flow
In the last 12 months, operating cash flow was 3.24B and capital expenditures -1.34B, giving a free cash flow of 1.90B billion.
Operating Cash Flow3.24B
Free Cash Flow1.90B
Free Cash Flow per Share11.32
Dividends & Yields
Dr. Lal PathLabs Limited pays an annual dividend of ₹7, resulting in a dividend yield of 0.89%
Dividend Per Share₹7
Dividend Yield0.89%
Payout Ratio84.34%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.60
52-Week Price Change3.32%
50-Day Moving Average1.38K
200-Day Moving Average1.49K
Relative Strength Index (RSI)52.83
Average Volume (3m)3.61K
Important Dates
Dr. Lal PathLabs Limited upcoming earnings date is Apr 30, 2026, TBA (Confirmed).
Last Earnings DateJan 30, 2026
Next Earnings DateApr 30, 2026
Ex-Dividend Date―
Financial Position
Dr. Lal PathLabs Limited as a current ratio of 3.39, with Debt / Equity ratio of 10.68%
Current Ratio3.39
Quick Ratio3.30
Debt to Market Cap<0.01
Net Debt to EBITDA-0.17
Interest Coverage Ratio25.13
Taxes
In the past 12 months, Dr. Lal PathLabs Limited has paid 1.33B in taxes.
Income Tax1.33B
Effective Tax Rate0.21
Enterprise Valuation
Dr. Lal PathLabs Limited EV to EBITDA ratio is 25.21, with an EV/FCF ratio of 37.90.
EV to Sales8.08
EV to EBITDA25.21
EV to Free Cash Flow37.90
EV to Operating Cash Flow34.95
Balance Sheet
Dr. Lal PathLabs Limited has ₹13.02B in cash and marketable securities with ₹2.55B in debt, giving a net cash position of ₹10.47B billion.
Cash & Marketable Securities₹13.02B
Total Debt₹2.55B
Net Cash₹10.47B
Net Cash Per Share₹62.48
Tangible Book Value Per Share₹84.36
Margins
Gross margin is 60.12%, with operating margin of 22.77%, and net profit margin of 19.79%.
Gross Margin60.12%
Operating Margin22.77%
Pretax Margin25.39%
Net Profit Margin19.79%
EBITDA Margin32.04%
EBIT Margin26.29%
Analyst Forecast
The average price target for Dr. Lal PathLabs Limited is ₹1,577.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target₹1,577.00
Price Target Upside7.06% Upside
Analyst ConsensusHold
Analyst Count1
Revenue Growth Forecast10.80%
EPS Growth Forecast32.79%